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INTRODUCTION 
Type 2 diabetes mellitus (T2DM) has 
become a worldwide health problem with a 
great deal of therapeutic expenses due to its 
complications. It has been estimated that the 
number of diabetic patients reaches to  
592 millions cases in 2035. In Iran, more 
than 4 millions of adults (8.34% of total 
population) suffered from type 2 diabetes 
mellitus.
1
 Diabetes affects all physical, 
emotional, and psychological aspects of 
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ABSTRACT 
Background and aims: Diabetes affects all physical, emotional, and psychological 
aspects of patient’s health. Postmenopausal diabetic women are more susceptible due to 
their crucial conditions. The emotional regulatory role of vitamin D may be because of 
the existence of its receptors distributed in brain areas involved in emotional processing 
and affective disorders. The aim of this study is to assess the effect of 3-mounth regular 
consumption of vitamin D-fortified low fat yogurt on QOL indices in diabetic 
postmenopausal women. 
Methods: Fifty nine postmenopausal diabetic women randomly allocated to the ‘FY’ 
(received vitamin D-fortified low fat yogurt, containing 2000 IU vitamin D in 100 g) or 
‘PY’ (received plain low fat yogurt without additive) treatment groups. The quality of life 
questionnaire SF-36 which is the most widely used method to assess the QOL was used 
before and after the intervention. 
Results: After the 3-month intervention, physical performance, vitality, and mental 
health scores significantly increased and the score of physical pain decreased in the FY 
group. In the PY group, physical performance, vitality, and emotional role scores 
significantly decreased. Final scores of physical performance and vitality significantly 
increased in the FY group compare to the PY group while physical? 
Conclusion: Three months daily consumption of 2000 IU vitamin D fortified low-fat 
yogurt improved physical performance, physical pain, and vitality while the other 
domains of QOL assessments did not show significant changes. 
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patients health. Postmenopausal diabetic 
women are more susceptible due to their 
crucial conditions like aging, probable  
co-morbidities such as osteoporosis, and 
socio-economic problems.
2 
Pateints with T2DM are in challeng 
with their disease because diabetes is a 
disabling chronic problem. Diabetes related 
distress, depression, and anxiety are 
emotional distresses that affect about 40% of 
the patients; therefore, the quality of life 
(QOL) will be affected.
3-5
 Patient satisfaction 
that is in interconnection with QOL, plays an 
important role in management of diabetes as 
well as self-care behaviors.
6 
Vitamin D is recognized as a factor not 
just involved in calcium homeostasis. The 
existence of vitamin D receptor in almost all 
cells and tissues justifies its extra-skeletal 
effects like anti-depressive, anti-anxiety,  
anti-inflammatory, immune-modulatory, 
insulin secretion, gene expression, and 
cardio-protection.
7
 The emotional regulatory 
role of vitamin D maybe because of the 
existence of  its receptors distributed in brain 
areas involved in emotional processing and 
affective disorders.
8
 Epidemiological studies 
showed that low levels of serum  
25-hydroxyvitamin D (25(OH)D) may 
contribute to emotional, spiritual, and physical 
disorders.
9
 Few studies assessed the effect of 
vitamin D on QOL of postmenopausal 
diabetic women.Motsinger et al. Conducted a 
cross-sectional study in old women of Iowa 
Womans Health Study and showed that 
subjects who consumed<400 IU vitamin D per 
day had significantly lower mental health 
related QOL compare to those received ≥400 
IU/day.
10
 Witham et al. Reported that 10 
weeks vitamin D supplementation with 
100,000 IU, did not improve the QOL in 
patients with heart failure. 
 
METHODS 
This study is a part of a randomized, 
placebo-controlled, double blinded, parallel 
group clinical trial on diabetic 
postmenopausal women registered at Isfahan 
Endocrine and Metabolism Research Center. 
The primary objective of this project was to 
evaluate the effects of 2000 IU/day vitamin 
D-fortified yogurt on glycemic control, 
anthropometric indices, and bone markers in 
type 2 diabetic postmenopausal women. The 
results were mentioned in our previous 
article.
2
 As the secondary objective, we 
assessed the effect of 12 weeks intervention 
on QOL of the participants. To compute the 
sample size, we used the suitable formula 
for parallel-design randomized controlled 
trials considering α=0.05, 90% power, and a 
standardized effect size of ∆=1 in N-
terminal type-1 collagen (one of the bone 
markers) as a key variable of primary goals.
2
 
Therefore, we needed 22 participants in each 
group but 30 subjects were considered for 
each groups to avoid missing the 
participants. postmenopausal women who 
had not menses for at least 12 months were 
selected and enrolled in the study if they met 
the inclusion criteria: (i) not taking any 
forms of vitamin D, calcium, or omega-3 
supplements within the past 3-month before 
the intervention, (ii) not taking drugs which 
have obvious interaction with vitamin D or 
influence its metabolism i.e. corticosteroids 
or estrogens, (iii) baseline serum 
25(OH)D<125 nmol/l, and (iv) not having 
history of malignancy, renal failure, liver, 
endocrinologic, or inflammatory disorders.
2
 
Briefly, postmenopausal women who had 
not menses for at least 12 months were 
selected and enrolled in the study if they met 
the inclusion criteria: (i) not taking any 
forms of vitamin D, calcium, or omega-3 
supplements within the past 3-month before 
the intervention, (ii) not taking drugs which 
have obvious interaction with vitamin D or 
influence its metabolism i.e. corticosteroids 
or estrogens, (iii) baseline serum 
25(OH)D<125 nmol/l, and (iv) not having 
history of malignancy, renal failure, liver, 
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endocrinologic, or inflammatory disorders. 
The study protocol was approved by the 
Ethical Committee of Research, Isfahan 
University of Medical Sciences (registration 
number: 192015). The study protocol and its 
progress were recorded at www.irct.ir 
(registration ID: IRCT2013110515294N1). 
At first, the study protocol and objectives 
were fully explained to each subject and 
then written informed consent was obtained 
from all participants. 
After 3 weeks running-in period, 
subjects were randomly divided to 2 groups. 
The equivalent amounts of dairy products 
were replaced by 100 g of low-fat yogurt per 
day in their diet. During the intervention, 
subjects who had any changes in type or 
dosage of oral anti-diabetic drugs or used 
insulin, received vitamin D, calcium or 
omega-3 supplements were excluded. 
We used random permuted block 
method. Each block had permuted,  
even-numbered, randomly varying block 
sizes with 1: 1 allocation ratio.The block 
sizes were hiden until the end of the study. 
Postmenopausal diabetic women were 
randomly allocated to the ‘FY’ (received 
vitamin D-fortified low fat yogurt, 
containing 2000 IU vitamin D in 100 g) or 
‘PY’ (received plain low fat yogurt 
without additive) treatment groups. An 
investigator uninvolved in recruiting the 
subjects performed the random sequence 
generation. Both participants and 
investigators were blinded to the content 
of interventions. 
In this study the quality of life 
questionnaire SF-36 which is the most 
widely used method to assess the QOL was 
used. The mentioned questionnaire includes 
36 questions that evaluates the quality of life 
in 8 domains; (i) physical performance, (ii) 
physical health, (iii) physical pain, (iv) 
general health, (v) vitality, (vi) social 
performance, (vii) emotional role, and (viii) 
mental health. Each question has a minimum 
of 2 and a maximum of 6 options to answer. 
The options for each questions is graded 
based on a scale of 0 to 100. The zero and 
one hundred scores show the lowest and the 
highest levels of performance, respectively. 
The total score for each domain is calculated 
from the sum of the scores in that domain 
divided by the number of questions. 
Therefore, the total QOL score of each 
domain ranges from 0 (the lowest score) to 
100 (the highest score).In another category, 
scores from 0 to 49 was classified as poor, 
50 to 74 as relatively favorable, and 75 and 
more was ranked as favorable. The SF-36 
questionnaire is a standard method designed 
by Ware et al. to measure the QOL of 
patients and healthy subjects.
12
 Its validity is 
approved and its reliability has been 
reported from a minimum of 0.73 in social 
performance to a maximum of 0.96 in 
emotional role.
13,14 
Demographic data, duration of daily sun 
exposure, durations of diabetes and 
menopause, concomitant diseases, drugs, 
smoking habits, and QOL were collected 
using questionnaires. The questionnaires 
were completed by 2 expert nurses not 
involved in the study. 
Quantitative data were expressed as  
mean ± SE and qualitative data were 
represented as number and percentage. 
Normality of studied variables was evaluated 
using Kolmogorove-Smirnov test and Q-Q 
plot. Positively skewed data were subjected to 
logarithmic transformation. Within-group 
Changes from baseline were assessed using 
paired-Student t-test for continuous variables 
or Mann-Whitney U test for non-normally 
distributed continuous variables. Pearson  
Chi-squared test was used to compare 
categorical variables. Between-group analyses 
were conducted using analysis of covariance 
(ANCOVA) in order to compare final values 
after adjusting the baselines. Data  
were entered and analyzed using the SPSS 
version 20. 
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RESULTS 
Among 93 subjects, 29 patients did not 
meet the inclusion criteria. The remaining 64 
patients were randomly divided in to FY or PY 
groups as previously explained. Five women 
were excluded during the intervention (week 3) 
due to change in treatment. Table 1 shows the 
general characteristics of 59 patients who 
completed the 3-month intervention. 
 
Table 1: General characteristics of participants at baseline 
Variables FY
a
(n=30) PY
b
(n=29) P
c 
Age(year) 57.8±5.5 56.8±5.7 0.47 
Diabetes duration(year) 9.3±5.3 8.8±4.8 0.70 
Menopausal duration(year) 8.1±6.2 8±4.5 0.94 
Physical activity(MET h
-1
 d
-1
) 23.4±1.8 23.3±2.0 0.94 
Sun exposure(minute/day) 24.7±11.0 23±11.2 0.84 
25-hydroxy vitamin D(nmol/l) 62.23±4.52 62.72±4.27 0.94 
Physical performance 46.96±3.16 58.48±3.26 0.02 
Physical health 54.39±3.30 53.46±3.24 0.84 
Physical pain 57.12±3.18 63.49±3.22 0.02 
General health 52.12±3.13 43.92±3.28 0.07 
Vitality 58.84±3.27 61.88±4.04 0.03 
Social performance 46.03±4.25 41.01±3.94 0.39 
Emotional role 50.31±3.77 46.08±3.29 0.40 
Mental health 40.26±3.26 43.78±4.13 0.52 
Total QOL score 48.00±1.32 51.51±1.17 0.53 
All presented values are means ± Ses; 
a
Fortified yogurt group; 
b
Plain yogurt group; 
c
Denote significance of within-group changes. 
 
The distribution of age, diabetes and 
menopausal duration, physical activity, 
sun exposure, and total QOL score did not 
differ significantly between 2 groups. 
Physical performance, physical pain, and 
vitality were significantly different 
between the 2 groups which considered in 
final analyses by adjusting for the baseline 
values. The percentages of patients taking 
oral antidiabetic drugs were as follows: 
metformin, 66.6% in FY group and 65.5% 
in PY group; glitazone, 10% in FY group 
and 10.4% in PY group; oral agent 
combination, 23.3% in FY group and 
24.1% in PY group. 
At start, 79.7% of subjects were 
vitamin D deficient or insufficient while at 
the end of the study period, the vitamin D 
status of the FY group was substantially 
improved: serum 25(OH)D significantly 
increased, and none of the subjects were 
deficient. Otherwise, in PY group, serum 
25(OH)D, even if not significantly 
decreased and the percentage of sufficient 
subjects lowered from 20.7% to 3.4% 
(Table 2). 
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Table 2: Comparison of baseline and final values of serum 25(OH)D and QOL domains 
Domain FYa group PYb group 
Before After Pc Before After Pc 
25(OH)D (nmol/l) 62.23±4.5 86.83±4.87 <0.001 62.72±4.27 56.13±2.89 0.27 
Physical performance 46.95±3.16 55.48±3.17 0.04 58.47±3.62 44.72±3.19 0.01 
Physical health 54.39±3.30 53.99±3.48 0.92 53.46±3.23 45.53±2.83 0.09 
Physical pain 53.12±3.18 42.91±2.24 <0.01 63.48±3.22 55.11±4.02 0.09 
General health 52.14±3.13 52.07±2.73 0.98 43.91±3.28 54.07±4.37 0.06 
Vitality 40.84±3.27 56.57±3.95 <0.01 61.88±4.04 40.62±3.68 <0.01 
Social performance 46.03±4.25 36.02±3.29 0.08 41.01±3.93 46.42±4.40 0.38 
Emotional role 50.30±3.77 53.72±3.24 0.50 46.08±3.29 54.66±3.60 0.02 
Mental health 40.25±3.66 59.09±3.60 <0.01 43.78±4.13 47.32±3.90 0.59 
Total QOL score 48.00±1.32 51.23±1.07 0.09 51.52±1.17 48.55±1.24 0.14 
All presented values are means ± Ses; 
a
Fortified yogurt; 
b
Plain yogurt; 
c
P-values denote significance of 
within-group changes (paired t-test). 
 
At baseline, 55.9% of participants had 
poor QOL scores. The remaining 44.1% had 
relatively favorable QOL scores. At the end 
of the intervention, the number of subjects 
with poor QOL score decreased in the FY 
group; however, in the PY group most of the 
subjects had poor QOL scores. There were 
no significant differences between the 2 
groups in QOL categories before and after 
the intervention (Table 3). 
 
Table 3: Distribution of participants based on QOL categories before and after the intervention 
Group Before intervention After intervention 
Poor
a 
Relatively favorable
b 
Favorable
c 
P
f
 Poor
a 
Relatively favorable
b 
Favorable
c 
P
f
 
FY
d
 [n(%)] 21(70) 9(30) 0(0) 0.07 12(40) 18(60) 0(0) 0.12 
PY
e
 [n(%)] 12(41.4) 17(50.6) 0(0)  17(58.6) 12(41.4) 0(0)  
Total [n(%)] 33(55.9) 26(44.1) 0(0)  29(49.9) 30(50.8) 0(0)  
a
Poor QOL (QOL score<49); 
b
Relatively favorable QOL (50<QOL score<74); 
c
Favorable QOL (QOL 
score>75); 
d
Fortified yogurt; 
e
Plain yogurt; 
f
Denotes the significance of differences in QOLcategories 
between the groups before and after the intervention (chi-squaretest). 
 
Compare to baseline, total QOL score in 
both groups did not significantly changed 
but trends of increase and decrease were 
seen in the FY group and the PY group, 
respectively (Table 2). 
After the 3-month intervention, physical 
performance, vitality, and mental health 
scores significantly increased and the score 
of physical pain decreased in the FY group. 
In the PY group, physical performance, 
vitality, and emotional role scores 
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significantly decreased (Table 2). Physical 
health, general health, social performance, 
and emotional role scores did not 
significantly changed in the FY group but a 
trend of reduction was observed in these 
scores after the intervention. In the PY 
group, the scores of physical health, general 
health, social performance, and mental role 
decreased but the results were not 
statistically significant (Table 2). 
Final scores of physical performance 
and vitality significantly increased in the FY 
group compare to the PY group while 
physical pain score was significantly 
decreased. The other domains of QOL 
assessment did not show significant 
differences between the groups (Table 4). 
 
Table 4: Effects of vitamin D fortified yogurt on QOL scores in type 2 postmenopausal women 
Domain FYgroup
a
 PY group
b
 P
c
 
Physical performance 55.27±3.35 44.95±3.41 0.04 
Physical health 53.91±3.28 45.62±3.34 0.08 
Physical pain 43.86±3.34 54.13±3.40 0.04 
General health 51.70±3.70 54.45±3.78 0.61 
Vitality 55.12±4.06 42.12±4.14 0.04 
Social performance 45.22±3.90 37.19±3.82 0.15 
Emotional role 52.96±3.35 55.45±3.441 0.60 
Mental health 57.79±3.43 48.66±3.49 0.07 
Total QOL score 50.88±1.18 48.92±1.98 0.26 
Variables are after intervention measurements and represented “estimated marginal means” ± SEs 
(Adjusted for baselines, age, diabetes duration, and menopausal duration); 
a
Fortified yogurt; 
b
Plain 
yogurt; 
c
P-values are resulted from ANCOVA for between group comparisons based on after 
intervention values. 
 
DISCUSSION 
Vitamin D is thought to affect cerebral 
functions and brain health through its 
receptors which are scattered throughout the 
brain especially in areas involved in 
behavioral regulation.
15
 Seasonal affective 
disorders as well as depression are associated 
with sunlight deprivation and winter months. 
It suggests an association between vitamin D 
deficiency and mood disorders.
16–18
 The 
inverse relationship between vitamin D 
intake and mood disorders are represented in 
some studies.
19–21
 Few studies assessed the 
effect of vitamin D on mood disorders in old 
people.
22
 
Elevated inflammatory condition and 
oxidative stress are hallmarks of diabetes 
which can damage neurons. Diabetes also 
affect the production, secretion, and 
regulation of neurotransmitters in the 
brain.
23
Amonge diabetic patients, elderly 
subjects especially women are more 
susceptible to develop mood 
disorders.Assessment of QOLin diabetic 
patients has been considered by 
researchers.
24,25
 Kashfi et al. compared the 
QOL of 124 diabetic patients with 124 
healthy similar subjects. They suggested that 
diabetes decreased the QOL of 
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patients.
26
Saadatjoo et al. 
10
 and Vazirinejad 
et al.
27
 also reported similar findings in their 
studies. Motsinger et al. evaluated the 
association between vitamin D intake and 
mental health-related QOL in older 
women.
22
They found that women who 
consumed <400 IU/day of vitamin D had 
significantly lower mental health-related 
QOL compared to those who consumed 
≥400 IU/day. Witham et al. used 100000 IU 
oral vitamin D2 supplements in vitamin D 
deficient-older patients with heart failure 
and repeated it after 10 weeks. They 
concluded that vitamin D supplementation 
did not improve functional capacity or 
QOL.
11
All of the mentioned studies used 
SF-36 questionnaire to evaluate the QOL. 
To our knowledge, this is the first study 
which assessed the effect of vitamin D on 
QOL and its domains, in diabetic 
postmenopausal women via consumption of 
a fortified food. We also reported the 
adjusted final scores for QOL and its sub 
domain instead of weak raw data that must 
be considered as strengths of the study. Our 
study had some limitations that are indicated 
in the following; we suggest that 3-month 
intervention may not be enough to improve 
all the aspects of QOL in type 2 diabetic 
postmenopausal women. In addition, older 
women, especially those with diabetes 
usually have very poor QOL, therefore, 
vitamin D alone or in the dose of 2000 IU 
which was used in this study may not be 
able to improve the QOL 
appropriately.Further precise studies are 
needed to achieve more clear and accurate 
consensus in this field. 
 
CONCLUSION 
Three months daily consumption of 
2000 IU vitamin D fortified low-fat yogurt 
improved serum 25(OH)D status of 
postmenopausal diabetic women. A trend of 
improvement was observed in the average 
total QOL score of patients in the FY group 
while in the PY group, a trend of 
deterioration was found. After adjustment for 
baseline scores, age, menopausal duration, 
and diabetes duration which thought to affect 
the QOL of patients, final scores of physical 
performance, physical pain, and vitality 
significantly improved in subjects who 
received vitamin D fortified yogurt while the 
other domains of QOL assessments did not 
show significant changes. 
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